University Hospital Essen at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
University Hospital Essen brings 3 presentations to ESGCT 2026 in Hamburg. Its work centres on CAR T and CAR NK cells for childhood and solid cancers, covering paediatric acute myeloid leukaemia, head and neck cancer and liver tumours. Approaches include curbing interleukin-15 toxicity and a single vector whose extra antibody is released only where oxygen is low.
| Organization | ESGCT 2026 Attendance |
|---|---|
University Hospital Essen Essen, Germany | |
Poster Wed Oct 28 1:30pm–3:30pm Establishing a Modular Strategy to Overcome IL15-Associated Toxicity in in vivo CAR NK-Cell Therapy for Pediatric AML in PDX Models Poster Wed Oct 28 1:30pm–3:30pm Preclinical evaluation of the immune checkpoint B7-H3 as target antigen for CAR T-cell therapy in 2D and 3D models of head/neck squamous cell carcinoma Poster Thu Oct 29 2:00pm–4:00pm Hypoxia-regulated BiTE secretion in single-vector CAR T-cells enables specific multi-antigen targeting of pediatric liver tumors |
Instantly find 20 buyers from University Hospital Essen
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction